Skip to main content
. 2023 Sep 19;24(18):14256. doi: 10.3390/ijms241814256

Figure 2.

Figure 2

The EGFR/EGFRvIII pathway contributes to the progression of GBM. While PI3K and RAS/MAPK activation is stronger in EGFRvIII-expressing cells, EGFRwt commonly stimulates MAPK and STAT3, encouraging tumor growth. Meanwhile, EGFRvIII is constitutively activated and primarily initiates the PI3K pathway, which is involved in tumor invasion and survival.